[Benoxaprofen in the treatment of spondylosis and spondylarthrosis (author's transl)].

An open clinical trial of 4 weeks included 32 patients with spondylosis and spondylarthrosis diagnosed on the average about 10 years previously. The non-steroid antirheumatic benoxaprofen was used alone in a dosage of a 1 x 600 mg tablet daily. The treatment had a marked influence on the clinical picture in the form of reduction of the pain at the beginning of movement, and of pains at night or on pressure.